Peptide record

TPDB77539

cationic AVP4-9 Blood-Brain Barrier modified_plain modified
19 source-reported length (unverified)
Basic Information
TPDB77539
cationic AVP4-9
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
Peptipedia
modified_plain
Yes
A modified blood-brain barrier peptide record curated from Peptipedia, without an available 3D structural model. Source-reported length: 19 (unverified).
C-terminal: Amidation Chemical: Cys3A-Cys3B
Sequence
Pyr-N(CPHR)CPRG-NH2

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
19 source-reported length (unverified)
Cys3A-Cys3B Activity
Linear Activity
Pyr-Asn-(Cys-Pro-His-Arg)-Cys-Pro-Arg-Gly-NH2 Activity
Evidence Records 5 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.0186 ml/g

Assay & Model

Capillary depletion
Capillary depletion (capillary/serum)

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.406 ml/g

Assay & Model

Capillary depletion
Capillary depletion (parenchyma/serum)

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
4.38%

Assay & Model

Capillary depletion
% capillary

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
95.62%

Assay & Model

Capillary depletion
% parenchyma

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
0.00031 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Saturable
Direct iodination
Additional Detail Fields 1 fields
Intravenous